APA (7th ed.) Citation

Blazejak, C., Stranzenbach, R., Gosman, J., Gambichler, T., Wehkamp, U., Stendel, S., . . . Assaf, C. (2022). Clinical outcomes of advanced-stage cutaneous lymphoma under low-dose gemcitabine treatment: Real-life data from the German cutaneous lymphoma network. Dermatology, 238(3), . https://doi.org/10.1159/000517830

Chicago Style (17th ed.) Citation

Blazejak, Christoph, et al. "Clinical Outcomes of Advanced-stage Cutaneous Lymphoma Under Low-dose Gemcitabine Treatment: Real-life Data from the German Cutaneous Lymphoma Network." Dermatology 238, no. 3 (2022). https://doi.org/10.1159/000517830.

MLA (9th ed.) Citation

Blazejak, Christoph, et al. "Clinical Outcomes of Advanced-stage Cutaneous Lymphoma Under Low-dose Gemcitabine Treatment: Real-life Data from the German Cutaneous Lymphoma Network." Dermatology, vol. 238, no. 3, 2022, https://doi.org/10.1159/000517830.